Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2
- PMID: 24587276
- PMCID: PMC3938662
- DOI: 10.1371/journal.pone.0090196
Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2
Abstract
The human gammaherpesviruses establish life-long infections that are associated with the development of lymphomas and neoplasms, especially in immunocompromised individuals. T cells play a crucial role in the control of gammaherpesvirus infection through multiple functions, including the direct killing of infected cells, production of cytokines such as interferon-γ (IFN-γ), and costimulation of B cells. Impaired T cell function in mice infected with murine gammaherpesvirus 68 (MHV68) leads to increased reactivation and pathologies, including a higher incidence of lymphoid hyperplasia. Here we report that the absence of Suppressor of TCR signaling -1 and -2 (Sts-1(-/-)/2(-/-)) during MHV68 infection leads to the generation of T cells with significantly heightened responses. Transient differences in the T and B cell response of infected Sts-1(-/-)/2(-/-) (Sts dKO) mice were also observed when compared to WT mice. However, these alterations in the immune response and the overall absence of Sts-1 and Sts-2 did not impact viral pathogenesis or lead to pathology. Acute lytic replication in the lungs, establishment of latency in the spleen and reactivation from latency in the spleen in the Sts dKO mice were comparable to WT mice. Our studies indicate that Sts-1 and Sts-2 are not required for the immune control of MHV68 in a normal course of gammaherpesvirus infection, but suggest that interference with negative regulators of T cell responses might be further explored as a safe and efficacious strategy to improve adoptive T cell therapy.
Conflict of interest statement
Figures




Similar articles
-
NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency.J Virol. 2009 May;83(10):4732-48. doi: 10.1128/JVI.00111-09. Epub 2009 Mar 4. J Virol. 2009. PMID: 19264770 Free PMC article.
-
Murine Gammaherpesvirus 68 Pathogenesis Is Independent of Caspase-1 and Caspase-11 in Mice and Impairs Interleukin-1β Production upon Extrinsic Stimulation in Culture.J Virol. 2015 Jul;89(13):6562-74. doi: 10.1128/JVI.00658-15. Epub 2015 Apr 8. J Virol. 2015. PMID: 25855746 Free PMC article.
-
Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.J Virol. 2014 Dec;88(24):14040-9. doi: 10.1128/JVI.02360-14. Epub 2014 Sep 24. J Virol. 2014. PMID: 25253356 Free PMC article.
-
Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner.J Virol. 2007 Jun;81(11):6134-40. doi: 10.1128/JVI.00108-07. Epub 2007 Mar 14. J Virol. 2007. PMID: 17360749 Free PMC article. Review.
-
Antigen expression during murine gamma-herpesvirus infection.Immunobiology. 2001 Dec;204(5):649-58. doi: 10.1078/0171-2985-00104. Immunobiology. 2001. PMID: 11846230 Review.
Cited by
-
TULA-2 Protein Phosphatase Suppresses Activation of Syk through the GPVI Platelet Receptor for Collagen by Dephosphorylating Tyr(P)346, a Regulatory Site of Syk.J Biol Chem. 2016 Oct 21;291(43):22427-22441. doi: 10.1074/jbc.M116.743732. Epub 2016 Sep 8. J Biol Chem. 2016. PMID: 27609517 Free PMC article.
-
TCR signaling promotes formation of an STS1-Cbl-b complex with pH-sensitive phosphatase activity that suppresses T cell function in acidic environments.Immunity. 2023 Dec 12;56(12):2682-2698.e9. doi: 10.1016/j.immuni.2023.11.010. Immunity. 2023. PMID: 38091950 Free PMC article.
-
Protection from systemic Candida albicans infection by inactivation of the Sts phosphatases.Infect Immun. 2015 Feb;83(2):637-45. doi: 10.1128/IAI.02789-14. Epub 2014 Nov 24. Infect Immun. 2015. PMID: 25422266 Free PMC article.
-
Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets.J Immunother Cancer. 2023 May;11(5):e005845. doi: 10.1136/jitc-2022-005845. J Immunother Cancer. 2023. PMID: 37217244 Free PMC article. Review.
References
-
- Heslop HE (2005) Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program: 260–266. - PubMed
-
- Thompson MP, Kurzrock R (2004) Epstein-Barr virus and cancer. Clin Cancer Res 10: 803–821. - PubMed
-
- Malnati MS, Dagna L, Ponzoni M, Lusso P (2003) Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies. Rev Clin Exp Hematol 7: 375–405. - PubMed
-
- Carbone A, Gloghini A (2008) KSHV/HHV8-associated lymphomas. Br J Haematol 140: 13–24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases